Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Report

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, II, III, IV), By Indication (Oncology, CNS), By Region (Asia Pacific, North America), And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-409-7
Number of Pages: 275
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Cell and Gene Therapy Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Cell and Gene Therapy Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Cardiology
- CNS
- Musculoskeletal
- Infectious diseases
- Dermatology
- Endocrine, metabolic, genetic
- Immunology & inflammation
- Ophthalmology
- Hematology
- Gastroenterology
- Others
Cell and Gene Therapy Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Cell and Gene therapy clinical trials market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - North America Cell and Gene therapy clinical trials market, By Indication
    - Oncology
    - Cardiology
    - CNS
    - Musculoskeletal
    - Infectious diseases
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - U.S.
    - U.S. Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - U.S Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Canada
    - Canada Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Canada Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- Europe
  - Europe Cell and Gene therapy clinical trials market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Europe Cell and Gene therapy clinical trials market, By Indication
    - Oncology
    - Cardiology
    - CNS
    - Musculoskeletal
    - Infectious diseases
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - U.K.
    - U.K. Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - U.K. Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Germany
    - Germany Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Germany Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - France
    - France Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - France Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Italy
    - Italy Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Italy Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Spain
    - Spain Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Spain Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Denmark
    - Denmark Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Denmark Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Sweden
    - Sweden Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Sweden Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Norway
    - Norway Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Norway Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- Asia Pacific
  - Asia Pacific Cell and Gene therapy clinical trials market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Asia Pacific Cell and Gene therapy clinical trials market, By Indication
    - Oncology
    - Cardiology
    - CNS
    - Musculoskeletal
    - Infectious diseases
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - Japan
    - Japan Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Japan Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - China
    - China Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - China Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - India
    - India Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - India Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Australia
    - Australia Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Australia Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Thailand
    - Thailand Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Thailand Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - South Korea
    - South Korea Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Korea Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- Latin America
  - Latin America Cell and Gene therapy clinical trials market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Latin America Cell and Gene therapy clinical trials market, By Indication
    - Oncology
    - Cardiology
    - CNS
    - Musculoskeletal
    - Infectious diseases
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - Brazil
    - Brazil Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Brazil Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Mexico
    - Mexico Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Mexico Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Argentina
    - Argentina Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Argentina Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- MEA
  - MEA Cell and Gene therapy clinical trials market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - MEA Cell and Gene therapy clinical trials market, By Indication
    - Oncology
    - Cardiology
    - CNS
    - Musculoskeletal
    - Infectious diseases
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - South Africa
    - South Africa Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Africa Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Saudi Arabia
    - Saudi Arabia Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Saudi Arabia Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - UAE
    - UAE Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - UAE Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Kuwait
    - Kuwait Cell and Gene therapy clinical trials market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Kuwait Cell and Gene therapy clinical trials market, By Indication
      - Oncology
      - Cardiology
      - CNS
      - Musculoskeletal
      - Infectious diseases
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others

Cell And Gene Therapy Clinical Trials Market Dynamics

Driver: Growing Interest in Cell and Gene Therapy

Cell and gene therapies can transform the pharmaceutical industry. Experts consider that the next generation of cell and gene therapies holds great potential as advanced personalized medicine. It creates a point-of-care that may cure several conditions. This is because cell and gene therapy is designed based on complete information regarding the origins of a disease. Cell and gene therapies witnessed less adoption in the pharmaceutical business as they are relatively new and still under experimental conditions. However, with increased research and higher coverage around the world, CGT is rapidly becoming one of the attractive fields of investment for pharma companies. CAR-T therapies developments are observed most notably in Novartis and Gilead. This therapy is gaining success at the forefront of the technology’s usage with the authorization of Yescarta and Kymriah. Such developments are anticipated to propel the overall market growth over the forecast period.

Driver: Adoption of New Technology In Clinical Research

It has been observed that the current way of conducting a traditional clinical trial is coming to an end as the increasing cost of running trials together with the commercial risk of failure is unsustainable. As progress is being made toward a more digitalized scenario, clinical studies are driven by the rising adoption of advanced technologies that rapidly accelerate the digital transformation of their processes. As clinical trials are not optional, shifting to advanced technology & digital innovation is a solution to combat the problems associated with traditional clinical trials. Digital clinical trials, which were just a concept earlier, are now on track to become a reality. Digital technology is transforming the entire process of drug development. The advent of mobile & wearables, artificial intelligence, cloud technology, and associated platforms now enable the collection of frequent, precise, and multidimensional data during the length of trials. These advanced technologies have the potential to enable innovative trial designs that lead to easy recruitment & retention, improve patient experience, and establish novel endpoints in clinical.

Restraint: Recruitment Obstacles

The success of cell and gene therapy clinical trials depends on the level of engagement of its clinical staff, oncologists, and patients from the very first phase. Unfortunately, several barriers are present within these groups for both psychological and logistical reasons. Consequently, less than 5% of adult patients diagnosed with cancer register in clinical trials. This is mainly due to various reasons including availability of trial, oncologist’s willingness to propose enrollment, site access, commitment of clinical staff, and patient concerns. Cancer researchers face a considerable challenge in patient recruitment. As of June 2019, approximately 14,000 oncology trials were actively recruiting with a participation rate of 3% to 8% of possible candidates, with an even more limited number in minority and geriatric populations. Low rate of enrollment poses risks to the success of specific clinical trials and may hamper treatment advances & corresponding benefits to outcomes. Despite the promise that clinical trials may improve cancer care, several cancer researchers discover themselves in severe competition for patients from a site perspective that makes perception & reality that recruitment is a labor-and time-intensive process.

What Does This Report Include?

This section will provide insights into the contents included in this cell and gene therapy clinical trials market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Cell and gene therapy clinical trials market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Cell and gene therapy clinical trials market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.